According to SNS Insider, the market size of urinary incontinence treatment devices was estimated at US$22.72 billion in 2021 and is expected to reach over US$48.69 billion by 2028, growing at a CAGR of 7.8 % in the forecast period 2022-2028.

This press release was originally distributed by SBWire

Pune, Maharashtra — (SBWIRE) – 09/03/2022 – SNSInsider.com releases a new market research study on “Urinary Incontinence Treatment Devices Market Size, Share, Trends and Growth Analysis 2022-2028”.

Urinary incontinence, also called urge incontinence, is an involuntary loss of urine when urinating. Urge incontinence occurs when the muscles around the bladder involuntarily contract, resulting in loss of control of the urinary sphincter. Urge incontinence is often embarrassing for people who suffer from it and can be emotionally and physically debilitating. Key factors driving the market growth are the increase in surgical treatments for urinary incontinence due to the increase in chronic diseases (kidney stones, pregnancy, paralysis and neuromuscular injuries) which have developed the need for innovative urinary catheters.

Get Sample Report Of Urinary Incontinence Treatment Devices Market (Includes Detailed TOC, Tables, Regional Analysis, Graphs & Charts) @ https://www.snsinsider.com/sample-request/1080

For more information or customization email us [email protected]

Major Company Profiles included in Urinary Incontinence Treatment Devices Market are:

-Boston Scientific Corporation
– Promdon Group
– Medtronic plc
– Ethicon US, LLC. (Johnson & Johnson)
– CR Bard, Inc. (Becton, Dickinson and Company)
– Coloplast Group

The market research study has neutrally shown the latest strategic developments and trends of the market participants on the basis of current industry standards. The reasons that prompted the major industrial corporations to adopt the synthetic sourcing of market products were also revealed throughout the market research for…